SELENOP and neoplasm: Figure 5D shows Kaplan-Meier curves in the four patients classes defined by combined tumor expression of SELENOP and GOS2: patients with SELENOP-low/GOS2-low, SELENOP-high/GOS2-low, and SELENOP-high/GOS2-high statutes showed similar OS and were thus merged in a single class (non-SELENOP-low/GOS2-high), which displayed 56% 2-year OS (95%CI 46–70).